CDC42 and cardiac hypertrophy: Our results are in agreement with those of the study by Birnbaum group, in which Cdc42 expression was greatly enhanced and was found to be responsible for cardiac hypertrophy and fibrosis, and HS-induced cardiac hypertrophy was prevented by the Cdc42-specific inhibitor ML141 in rats [27].